Merck to acquire Prometheus Biosciences for $10.8bn
Prometheus is a clinical-stage biotechnology company engaged in the discovery, development, and marketing of novel therapeutic and companion…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Apr 23
Prometheus is a clinical-stage biotechnology company engaged in the discovery, development, and marketing of novel therapeutic and companion…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Apr 23
The data from the late-stage study showed a statistically significant improvement in RFS in people with HCC at…
14 Apr 23
The new-generation GlucoMetrics platform comes with significant enhancements that enable glycaemic management committees and hospitals to access key…
14 Apr 23
The FDA has also provided guidance and regulatory alignment to advance SAB-176 into the next phase of development,…
13 Apr 23
As part of the clinical trial support agreement, ESSA will sponsor and conduct a Phase 1 trial of…
13 Apr 23
Powered by ImmunoLin, Daiwa GastroImmune is said to be the next generation of immune system boosters that balances…
13 Apr 23
First Pringles x Minecraft collaboration delivers a previously only imagined Minecraft flavor to snacking
13 Apr 23
Kellogg is partnering with The Natasha Allergy Research Foundation to support up to three million people and their…
13 Apr 23
Global food player invests in new biotech startup to partner and create a new and disruptive generation of…
13 Apr 23
Report calls for approaches to build sustainable food and nutrition security and avert future crises